DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Share Price

Certificat

DE000ME9ZQQ9

Real-time Bid/Ask 09:04:03 03/07/2024 pm IST
123.92 EUR / 123.95 EUR -2.96% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.78%
1 month+5.56%
Date Price Change
03/24/03 125.9 -1.39%
02/24/02 127.7 -1.41%
01/24/01 129.5 +0.64%
28/24/28 128.7 -0.05%
27/24/27 128.8 -0.25%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 06:49 pm IST

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME9ZQQ
ISINDE000ME9ZQQ9
Date issued 11/03/2024
Cap 150 $
Last trading day 20/09/2024
Maturity 20/09/2024 (79 Days)
Parity 1 : 1
Emission price 118.9
Emission volume N/A
Payment day 27/09/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 2.742 %
Sideways yield 2.840 %
Sideways yield pa 13.12 %
Outperformance point 154.2 $
Break even 134.46 €
Highest since issue 129.5
Lowest since issue 111.1
Spread 0.04
Spread %0.03%
Distance Cap -12.41 $
Distance Cap %-9.02%
Max. earning 14.39
Max. earning % 11.56 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus